620 related articles for article (PubMed ID: 8169855)
1. Vascular reactivity to angiotensin II is selectively enhanced in the kidneys of spontaneously hypertensive rats.
Kost CK; Herzer WA; Li P; Jackson EK
J Pharmacol Exp Ther; 1994 Apr; 269(1):82-8. PubMed ID: 8169855
[TBL] [Abstract][Full Text] [Related]
2. Enhanced slow-pressor response to angiotensin II in spontaneously hypertensive rats.
Li P; Jackson EK
J Pharmacol Exp Ther; 1989 Dec; 251(3):909-21. PubMed ID: 2557422
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II: enhanced renal responsiveness in young genetically hypertensive rats.
Vyas SJ; Jackson EK
J Pharmacol Exp Ther; 1995 May; 273(2):768-77. PubMed ID: 7752079
[TBL] [Abstract][Full Text] [Related]
4. The inhibitory effect of angiotensin II on stimulus-induced release of cAMP is augmented in the genetically hypertensive rat kidney.
Vyas SJ; Mi Z; Jackson EK
J Pharmacol Exp Ther; 1996 Oct; 279(1):114-9. PubMed ID: 8858983
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II-induced renal vasoconstriction in genetic hypertension.
Jackson EK; Herzer WA; Vyas SJ; Kost CK
J Pharmacol Exp Ther; 1999 Oct; 291(1):329-34. PubMed ID: 10490921
[TBL] [Abstract][Full Text] [Related]
6. Low-dose angiotensin II reduces urinary cyclic AMP excretion in spontaneously hypertensive, but not normotensive, rats: independence from hypertension and renal hemodynamic effects of angiotensin.
Jackson EK; Herzer WA; Mi Z; Vyas SJ; Kost CK
J Pharmacol Exp Ther; 1999 Oct; 291(1):115-23. PubMed ID: 10490894
[TBL] [Abstract][Full Text] [Related]
7. Effect of angiotensin-converting enzyme two-week inhibition on renal angiotensin II receptors and renal vascular reactivity in SHR.
Haddad G; Garcia R
J Mol Cell Cardiol; 1997 Feb; 29(2):813-22. PubMed ID: 9140837
[TBL] [Abstract][Full Text] [Related]
8. Characterization and hemodynamic implications of renal vascular angiotensin II receptors in SHR.
Haddad G; Garcia R
J Mol Cell Cardiol; 1996 Feb; 28(2):351-61. PubMed ID: 8729067
[TBL] [Abstract][Full Text] [Related]
9. Effects of des-aspartate-angiotensin I on the actions of angiotensin III in the renal and mesenteric vasculature of normo- and hypertensive rats.
Mustafa MR; Dharmani M; Kunheen NK; Sim MK
Regul Pept; 2004 Aug; 120(1-3):15-22. PubMed ID: 15177916
[TBL] [Abstract][Full Text] [Related]
10. Enhanced in vivo responsiveness of presynaptic angiotensin II receptor-mediated facilitation of vascular adrenergic neurotransmission in spontaneously hypertensive rats.
Cline WH
J Pharmacol Exp Ther; 1985 Mar; 232(3):661-9. PubMed ID: 2983066
[TBL] [Abstract][Full Text] [Related]
11. Effects of deoxycorticosterone on renal vascular reactivity and flow-pressure curve in spontaneously hypertensive rats.
Chamorro V; Moreno JM; Wangensteen R; Sainz J; Rodriguez-Gomez I; Osuna A; Vargas F
J Physiol Pharmacol; 2004 Mar; 55(1 Pt 1):17-26. PubMed ID: 15082864
[TBL] [Abstract][Full Text] [Related]
12. Different reactivity to angiotensin II of peripheral and renal arteries in spontaneously hypertensive rats: effect of acute and chronic angiotensin converting enzyme inhibition.
Guidi E; Hollenberg NK
J Hypertens Suppl; 1986 Dec; 4(6):S480-2. PubMed ID: 11538668
[TBL] [Abstract][Full Text] [Related]
13. Evidence for a captopril-sensitive angiotensin converting enzyme in the hindquarter vasculature of SHR and WKY.
Mueller SM; Cohen ML
Artery; 1985; 12(6):337-45. PubMed ID: 2996465
[TBL] [Abstract][Full Text] [Related]
14. Captopril avoids hypertension, the increase in plasma angiotensin II but increases angiotensin 1-7 and angiotensin II-induced perfusion pressure in isolated kidney in SHR.
Castro-Moreno P; Pardo JP; Hernández-Muñoz R; López-Guerrero JJ; Del Valle-Mondragón L; Pastelín-Hernández G; Ibarra-Barajas M; Villalobos-Molina R
Auton Autacoid Pharmacol; 2012 Oct; 32(3 Pt 4):61-9. PubMed ID: 22994939
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II-induced changes in G-protein expression and resistance of renal microvessels in young genetically hypertensive rats.
Vyas SJ; Blaschak CM; Chinoy MR; Jackson EK
Mol Cell Biochem; 2000 Sep; 212(1-2):121-9. PubMed ID: 11108143
[TBL] [Abstract][Full Text] [Related]
16. Regional vascular selectivity of angiotensin II.
Jackson EK; Herzer WA
J Pharmacol Exp Ther; 2001 May; 297(2):736-45. PubMed ID: 11303065
[TBL] [Abstract][Full Text] [Related]
17. Low concentrations of angiotensin II unmask vasoconstrictory alpha 2-adrenoceptors in isolated perfused kidneys of spontaneously hypertensive rats.
Bohmann C; Rist W; Schollmeyer P; Rump LC
Cardiovasc Res; 1995 Dec; 30(6):857-65. PubMed ID: 8746199
[TBL] [Abstract][Full Text] [Related]
18. Defective modulation of noradrenergic neurotransmission by endogenous prostaglandins in aging spontaneously hypertensive rats.
Jackson EK
J Pharmacol Exp Ther; 1989 Jul; 250(1):9-21. PubMed ID: 2545868
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Ang II and renal sympathetic nerve influence dopamine-and isoprenaline-induced renal haemodynamic changes in normal Wistar-Kyoto and spontaneously hypertensive rats.
Abdulla MH; Sattar MA; Abdullah NA; Hazim AI; Anand Swarup KR; Rathore HA; Khan MA; Johns EJ
Auton Autacoid Pharmacol; 2008 Oct; 28(4):95-101. PubMed ID: 18778332
[TBL] [Abstract][Full Text] [Related]
20. Comparison of angiotensin II-induced blood pressure and structural changes in Fischer 344 and Wistar Kyoto rats.
Blanc J; Lacolley P; Laurent S; Elghozi JL
Clin Exp Pharmacol Physiol; 2004 Jul; 31(7):466-73. PubMed ID: 15236636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
